Susceptibility of clinical strains of bacteria to cefoxitin
Bremner, D.A.
New Zealand Medical Journal 94(691): 173-174
1981
ISSN/ISBN: 0028-8446 PMID: 6945507 Document Number: 175446
The susceptibility of 3044 bacterial strains isolated from patients at Auckland Hospital were tested by the disc diffusion of cefoxitin, cephalothin and ampicillin. 86.5 percent of these strains were sensitive to cefoxitin, 71.3 percent sensitive to cephalothin and 41.6 percent ot ampicillin. A significant difference between cefoxitin and cephalothin was observed with E. coli, Klebsiella, Enterobacter and Proteus species. S. epidermidis alone showed significantly less strains susceptible to cefoxitin than cephalothin.
Document emailed within 1 workday
Related Documents
Sawicka-Grzelak, A.; Rokosz, A. 1998: Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics Medycyna Doswiadczalna i Mikrobiologia 50(1-2): 69-76Deguchi, K.; Fukayama, S.; Nishimura, Y.; Nishike, A.; Oda, S.; Sato, S.; Matsumoto, Y.; Ikegami, R.; Yokota, N.; Tanaka, S. 1985: Distribution and changes in the susceptibility of bacteria isolated from clinical samples. Ii Japanese Journal of Antibiotics 38(6): 1587-1602
Deguchi, K.; Fukayama, S.; Nishimura, Y.; Nishike, A.; Oda, S.; Sato, S.; Matsumoto, Y.; Ikegami, R.; Yokota, N.; Tanaka, S. 1985: Distribution and changes in the susceptibility of bacteria isolated from clinical samples. IIi Japanese Journal of Antibiotics 38(6): 1603-1618
Reśliński, A.; Gospodarek, E.; Mikucka, A. 2005: Prevalence of multidrug-resistant Proteus spp. strains in clinical specimens and their susceptibility to antibiotics Medycyna Doswiadczalna i Mikrobiologia 57(2): 175-184
Gün, H.; Kocabeyoğlu, O.; Yilmaz, E.; Güngör, S.; Eren, A. 1988: Identification of pathogenic Escherichia coli strains in various clinical material and their antibiotic susceptibility Mikrobiyoloji Bulteni 22(3): 205-214
Babić, I.; Jelić, I.; Stanojević, D. 1980: An investigation of the antibacterial activity of cefoxitin against anaerobic and aerobic bacteria in vitro Lijecnicki Vjesnik 102(7-8): 414-416
Belokrysenko, S.S.; Riazanova, L.A.; Dugasheva, L.G.; Beloborodov, I.V. 1980: Temperature sensitivity of R-plasmid transfer by clinical strains of bacteria of the family Enterobacteriaceae Antibiotiki 25(2): 112-117
Sazykin, A.I.; Navashin, S.M. 1984: Substrate specificity of the beta-lactamases found in a number of clinical strains of gram-negative bacteria Antibiotiki 29(9): 657-661
Savel'ev, V.N.; Babenyshev, B.V.; Savel'eva, I.V.; Vasil'eva, O.V.; Guseva, L.V.; Grizhebovskiĭ, G.M.; Kurbanov, S.Kh.; Asvarov, B.M.; Batyrova, B.A.; Doroshenko, I.G.; Antonenko, A.D. 2010: Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic Antibiotiki i Khimioterapiia 55(5-6): 8-13
Endimiani, A.; Luzzaro, F.; Tamborini, A.; Lombardi, G.; Elia, V.; Belloni, R.; Toniolo, A. 2002: Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System New Microbiologica 25(3): 323-329
Wultańska, D.; Obuch-Woszczatyński, P.; Pituch, H.; Luczak, Mław. 2007: Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents Medycyna Doswiadczalna i Mikrobiologia 59(2): 161-168
Schwarz, S.; Böttner, A.; Hafez, H.M.; Kehrenberg, C.; Kietzmann, M.; Klarmann, D.; Klein, Günter.; Krabisch, P.; Kühn, T.; Luhofer, G.; Richter, A.; Traeder, W.; Waldmann, K-Heinz.; Wallmann, Jürgen.; Werckenthin, C. 2003: Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications Berliner und Munchener Tierarztliche Wochenschrift 116(9-10): 353-361
Tancrede, C.; Mariel, C.; Chaigneau, H.; Eveno, J. 1981: In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients La Nouvelle Presse Medicale 10(8): 545-547
Reali, D.; Rosati, S. 1994: Antibiotic susceptibility and serotyping of Pseudomonas aeruginosa strains isolated from surface waters, thermomineral waters and clinical specimens Zentralblatt für Hygiene und Umweltmedizin 196(1): 75-80
Yanagisawa, K.; Hoshina, H.; Ichihashi, H. 1981: A clinical study of cefoxitin in children Japanese Journal of Antibiotics 34(3): 305-309
Iwasa, H.; Mimura, K.; Terashima, H.; Hiraide, H.; Mizoguchi, O.; Kanabe, S.; Tamaki, K.; Kurokawa, T.; Hatsuse, K.; Takemura, K.; Kadota, T.; Ohsaki, Y. 1981: Clinical experience with cefoxitin in surgical field Japanese Journal of Antibiotics 34(6): 828-831
Motohiro, T.; Sakata, Y.; Fujimoto, T.; Nishiyama, T.; Nakajima, T.; Ishimoto, K.; Tominaga, K.; Yamashita, F.; Araki, H.; Takajo, N.; Tsugawa, S.; Nagayama, K.; Tanaka, Y.; Yuasa, A.; Koga, M.; Komatsu, Y.; Yamamoto, M.; Iriki, T.; Yoshioka, K.; Haraguchi, K.; Okada, S.; Imuta, F.; Kinoshita, M. 1981: Laboratory and clinical evaluation of cefoxitin in children Japanese Journal of Antibiotics 34(3): 384-403
Wikler, M.A. 1990: Interchangeability of ceftizoxime and cefoxitin: a clinical perspective Clinical Therapeutics 12 Suppl C: 74-79
Van der Westhuyzen, I.; Chalkley, L.J. 1992: Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg South African Medical Journal 82(5): 314-317
Shore, K.P.; Pottumarthy, S.; Morris, A.J. 1999: Susceptibility of anaerobic bacteria in Auckland: 1991-1996 New Zealand medical journal 112(1099): 424-426